SDLPharmaceuticals
Southern Palladium Ltd — PE Ratio & Valuation Analysis
₹34.93
+0.00%
Current P/EN/AxPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E24.4x100.0% below avg
✅
100.0% Discount to Industry
SDL P/E N/Ax vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹1.43 | ₹35 | 24.4x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Southern Palladium Ltd Valuation
Southern Palladium Ltd (SDL) currently trades at N/Ax earnings. The Pharmaceuticals sector average PE is 31.77x. Historically, SDL has traded at an average PE of 24.4x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
N/A
Dividend Yield
0.00%
More on Southern Palladium Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.